Metrics as of 10/14/2026, 09:06 AM (Berlin time), refresh in progress.
Sanara MedTech Stock
Sanara MedTech Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Seth D. Yon
- Employees
- 108
- Market cap
- $323 M
- IPO
- 07/04/1994
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and…
Sanara MedTech stock: price history
1D
-0.1%
1W
+0.2%
1M
+0.4%
6M
+75.5%
YTD
+50.4%
1Y
+17.2%
2Y
+10.2%
5Y
+6.5%
10Y
+602.4%
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~48% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Sanara MedTech stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Sanara MedTech Inc. develops and distributes specialized medical products for wound and skin care in the United States. Its product portfolio includes various collagen products such as CellerateRX, antimicrobial cleansers for biofilm management, and biological materials such as extracellular matrices and amniotic tissue. These solutions are primarily used for treating surgical wounds and chronic conditions such as pressure ulcers and diabetic foot wounds. The customer base encompasses a broad range of medical facilities, including hospitals, clinics, and long-term care facilities.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Regulatory
- Capital intensity
- Medium
- Customer concentration
- Low
Ask the agents about Sanara MedTech
Analyst assessment of Sanara MedTech
PRICE TARGET LOW
US$35.00
CONSENSUS
US$35.00
MEDIAN
US$35.00
PRICE TARGET HIGH
US$35.00
0
STRONG BUY
2
BUY
1
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 30/07/2026
Sanara MedTech stock metrics
P/E
-9.45
P/B
38.3
EV/EBITDA
37.62
RETURN ON EQUITY
-5.7%
NET MARGIN
-1.6%
DEBT/EQUITY
6.11
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
34.6%
FLOAT SHARES
3,183,382
AVG. DAILY VOLUME (30D)
206,601
Insider transactions (SEC)
Yon Seth D
Mack Roszell III
Major Eric D
Myers Keith G
Nixon Ronald T
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Sanara MedTech stock
What does Sanara MedTech do?
Sanara MedTech Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Seth D. Yon, the company employs around 108 people.
The IPO was on 07/04/1994; the stock trades on NASDAQ under the ticker SMTI.
What do analysts say about Sanara MedTech stock?
3 analysts rate the stock, the consensus is Buy (as of 30/07/2026).
The average price target is US$35.00, ranging from US$35.00 to US$35.00, with a median of US$35.00.
This is an external assessment, not a statement by Market Jury.
When does Sanara MedTech report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly -48% stronger than usual.
Does Sanara MedTech pay a dividend?
Yes. The last dividend was US$33.00 per share.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Sanara MedTech?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Sanara MedTech stock analyzed?
Clicking "Analyze stock" lets five strategies assess Sanara MedTech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.